Roth Capital Forecasts IMAX’s Q1 Earnings (NYSE:IMAX)

IMAX Co. (NYSE:IMAXFree Report) – Research analysts at Roth Capital lowered their Q1 2025 earnings per share (EPS) estimates for IMAX in a research note issued to investors on Thursday, February 20th. Roth Capital analyst E. Handler now expects that the company will earn $0.11 per share for the quarter, down from their prior forecast of $0.12. The consensus estimate for IMAX’s current full-year earnings is $0.91 per share. Roth Capital also issued estimates for IMAX’s Q2 2025 earnings at $0.19 EPS and Q3 2025 earnings at $0.20 EPS.

IMAX (NYSE:IMAXGet Free Report) last announced its quarterly earnings results on Wednesday, February 19th. The company reported $0.17 EPS for the quarter, missing analysts’ consensus estimates of $0.31 by ($0.14). IMAX had a net margin of 7.40% and a return on equity of 8.60%. The firm had revenue of $92.67 million for the quarter, compared to the consensus estimate of $104.08 million.

Several other equities research analysts also recently weighed in on IMAX. Rosenblatt Securities increased their price target on IMAX from $28.00 to $35.00 and gave the stock a “buy” rating in a report on Thursday. Macquarie increased their price target on IMAX from $28.00 to $30.00 and gave the stock an “outperform” rating in a report on Thursday. JPMorgan Chase & Co. increased their price target on IMAX from $25.00 to $27.00 and gave the stock a “neutral” rating in a report on Friday. Benchmark reissued a “buy” rating and issued a $30.00 price objective on shares of IMAX in a research note on Thursday. Finally, Wedbush reissued an “outperform” rating and issued a $32.00 price objective on shares of IMAX in a research note on Thursday. Two investment analysts have rated the stock with a hold rating, eight have given a buy rating and one has given a strong buy rating to the company. According to MarketBeat, IMAX presently has a consensus rating of “Moderate Buy” and a consensus price target of $30.67.

Check Out Our Latest Analysis on IMAX

IMAX Price Performance

Shares of IMAX stock opened at $26.03 on Monday. IMAX has a 1 year low of $14.94 and a 1 year high of $27.77. The stock’s 50 day simple moving average is $24.65 and its two-hundred day simple moving average is $23.03. The company has a market cap of $1.38 billion, a PE ratio of 53.11, a price-to-earnings-growth ratio of 1.49 and a beta of 1.22.

Institutional Investors Weigh In On IMAX

Hedge funds and other institutional investors have recently bought and sold shares of the stock. Janney Montgomery Scott LLC increased its stake in IMAX by 1.9% in the fourth quarter. Janney Montgomery Scott LLC now owns 29,176 shares of the company’s stock valued at $747,000 after purchasing an additional 533 shares during the period. Blue Trust Inc. increased its stake in IMAX by 138.5% in the fourth quarter. Blue Trust Inc. now owns 966 shares of the company’s stock valued at $25,000 after purchasing an additional 561 shares during the period. MetLife Investment Management LLC increased its stake in IMAX by 3.4% in the fourth quarter. MetLife Investment Management LLC now owns 25,918 shares of the company’s stock valued at $664,000 after purchasing an additional 848 shares during the period. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. increased its stake in IMAX by 3.9% in the fourth quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 24,395 shares of the company’s stock valued at $625,000 after purchasing an additional 905 shares during the period. Finally, US Bancorp DE increased its stake in IMAX by 23.4% in the third quarter. US Bancorp DE now owns 7,656 shares of the company’s stock valued at $157,000 after purchasing an additional 1,452 shares during the period. 93.51% of the stock is currently owned by institutional investors and hedge funds.

Insider Transactions at IMAX

In other news, insider Kenneth Ian Weissman sold 6,309 shares of the firm’s stock in a transaction on Monday, December 9th. The shares were sold at an average price of $25.51, for a total value of $160,942.59. Following the sale, the insider now directly owns 25,139 shares in the company, valued at approximately $641,295.89. This trade represents a 20.06 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, CFO Natasha Fernandes sold 2,957 shares of the firm’s stock in a transaction on Monday, December 9th. The shares were sold at an average price of $25.52, for a total transaction of $75,462.64. Following the completion of the sale, the chief financial officer now owns 14,883 shares in the company, valued at $379,814.16. The trade was a 16.58 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last three months, insiders have sold 65,176 shares of company stock worth $1,662,110. 24.08% of the stock is currently owned by insiders.

About IMAX

(Get Free Report)

IMAX Corporation, together with its subsidiaries, operates as a technology platform for entertainment and events worldwide. The company operates in two segments, Content Solutions and Technology Products and Services. The company offers IMAX DMR, a proprietary technology that digitally remasters films and other content into IMAX formats for distribution to the IMAX network; IMAX Enhanced that provides end-to-end technology across streaming content and entertainment devices at home; and SSIMWAVE, an AI-driven video quality solutions for media and entertainment companies.

Read More

Earnings History and Estimates for IMAX (NYSE:IMAX)

Receive News & Ratings for IMAX Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for IMAX and related companies with MarketBeat.com's FREE daily email newsletter.